Product
description
Subscription to La Meries
proprietary Antibody Pipeline Database provides online access to more than
1,600 project entries for therapeutic antibodies on the market and in research
& development. Each project is specified for its Target or Mechanism of
Action, Therapeutic Area and R&D Phase. Use of the R&D database of
therapeutic antibodies is intuitive. Data sets of interest can be printed and
exported. Projects are being updated continuously. The R&D history of each
project with online references of information sources can be viewed and
printed. Sales figures of major products are provided. The projects can be
segmented into Territories, Therapeutic Areas and R&D Phases. An advanced
search function allows to combine search parameters. A scroll down menu for
predefined targets conveniently selects projects of interest. By clicking on
column heads of the project list, projects can be arranged in ascending or
descending alphabetical or numerical order, e.g. for phase, product category or
company name.
Purchase of the subscription
provides a 1-year online access to the data of the Antibody Pipeline Database.
Credentials to access the database will be sent by e-mail within 24 hours after
purchase.
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/antibody-pipeline-database-1-year-subscription
Benefits from the Antibody Pipeline
Database:
- New database with no historical burden
- Intuitive use
- Designed for structured searches
- Focused on targets, therapeutic areas and R&D phases
- Ideal for competitor analysis (companies, targets, product categories)
- Cost-effective and rapid solution for benchmarking
- Identification of licensing candidates
Project listing in a tabular format:
- Drug Codes
- Target / Mechanism of Action
- Class of Compound
- Product Category
- Company
- Territory
- Therapeutic Area
- Indication
- R&D Phase
Therapeutic Areas:
- Cardiovascular & blood
- Dermatology
- Gastrointestinal
- Genitourinary, renal & gynecology
- Infectious & toxicology
- Metabolism & endocrine
- Neurology & psychiatry
- Oncology
- Ophthalmology & otorhinolaryngology
- Orthopedics, dental, anesthesia & surgery
- Pulmonary & respiratory
- Rheumatoid & autoimmune
Predefined Targets of the Scroll
Down Menu:
- Anti-Infective Antibodies
- Antibody-Drug Conjugates (ADC)
- Biosimilar & Biobetter/Biosuperior Antibodies
- c-MET/HGF Inhibitors
- CD3 Antagonists
- CD19 Antagonists
- CD20 Antibodies
- CD22 Antibodies
- CD30 Antibodies
- CD40/L
- CEA Antibodies
- Death Receptors TRAIL-R1/2
- EGF-R Agonists and Antagonists
- EpCAM Antagonists
- GM-CSF Antibodies
- Her2 Antagonists
- IGF-1R Antagonists
- Immunocytokines
- Immunotoxins
- Interleukin-1/R Antagonists
- Interleukin-6/R Antagonists
- Interleukin-12/23 Antagonists
- Interleukin-13 Antagonists
- Interleukin-17 Antagonists
- Integrin Antagonists
- NGF Antagonists
- PDGF-R Agonists and Antagonists
- TGF-R Agonists and Antagonists
- TNF Antagonists
- TRAIL-R1/R2 (Death Receptors)
- VEGF and VEGF-R Agonists and Antagonists
To
Buy The Copy of This Report Visit:
http://www.marketresearchreports.biz/analysis/139854
About Us
MarketResearchReports.Biz is the most comprehensive
collection of market research reports. MarketResearchReports.Biz services are
especially designed to save time and money of our clients. We are a one stop
solution for all your research needs, our main offerings are syndicated
research reports, custom research, subscription access and consulting services.
We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Blog: http://industry-research-reports.blogspot.com/
No comments:
Post a Comment